Inventor

WEBER ALFRED

AT65 patents

⚠️ This page may combine multiple inventors who share the name “WEBER ALFRED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WEBER ALFRED

SCHERING AG

Microbiological degradation of sterol side chains to a 17-keto group

Process for wastewater purification

Process for the production of 4-androstene-3,17-dione and 1,4-androstadiene-3,17-dione from ergosterol with mycobacterium

Process for the preparation of 4-androstene-3,17-dione derivatives

Process for the preparation of l-amino acids and amino acid amides

Novel 17-substituted 11 β-hydroxy steroids of the pregnane series, their manufacture, preparation and use

Method for isolation of 3-hydroxy steroids and 3-keto steroids

Novel steroids of the pregnane series, substituted in the 17-position, their manufacture and their use

Preparation of 3-oxo-Δ1,4 -steroids

Process for the preparation of 11β,21-dihydroxy-2&#39;-methyl-5&#39;βH-1,4-pregnadieno(16,17-D)-oxazole-3,20-dione

Process for the preparation of 4-androstene-3,17-dione derivatives

Process for the preparation of androstane-3,17-dione derivatives

Process for the preparation of 21-hydroxy-20-methylpregnane derivatives

Microbiological conversion of sterol derivatives to 5-androsten-17-one derivatives and their use

Process for the production of 17 α-hydroxy-3-methoxy-8,14-seco-1,3,5(10),9(11)estratetraen-14-one by reduction of the corresponding 17-one compound

Process for the production of arabinonucleotides

Process for the preparation of 4-androstene-3,17-dione and 1,4-androstadiene-3,17-dione

Process for the extraction of amino acids from an aqueous phase

Process for the production of ergoline derivatives

Process for the production of arabinonucleosides

Fermentation process for the production of β-carboline derivatives by Myrothecium verrucaria

Process for production of 6α,9α-difluoro-11β,17α-dihydroxy-16α-methyl-4-pregnene-3,20-dione and its derivatives

BAXALTA INC

Removal of serine proteases by treatment with finely divided silicon dioxide

Removal of serine proteases by treatment with finely divided silicon dioxide

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggs

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs

Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs

Removal of serine proteases by treatment with finely divided silicon dioxide

Removal of serine proteases by treatment with finely divided silicon dioxide

Ethanol dependence of alpha1 antitrypsin C-terminal Lys truncation by basic carboxypeptidases

TAKEDA PHARMACEUTICALS CO

Removal of serine proteases by treatment with finely divided silicon dioxide

Human plasma-derived IGG preparation enriched in anti-parvo B19 natural IGGS

Anti-factor IX padua antibodies

Anti-factor IX Padua antibodies

BAXTER INT

Removal of serine proteases by treatment with finely divided silicon dioxide

Removal of serine proteases by treatment with finely divided silicon dioxide

Measurement of autoantibodies at low conductivity with increased sensitivity

TESCHNER WOLFGANG

Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof

Removal of serine proteases by treatment with finely divided silicon dioxide

WEBER ALFRED

Methods for differentiating plasma-derived protein from recombinant protein in a sample

Modification-dependent activity assays

ALUSUISSE

Process and device for mounting a fastening element to a composite panel

Panel for a seat

VOEST ALPINE IND ANLAGEN

Process and installation for producing molten steel of scrap

Scrap-melting electric arc furnace

VOEST ALPINE INDUSTRIANLAGENBA

Plant for the production of molten metals and method

OERTLI WERKZEUGE AG

Woodworking milling cutter particularly for grooving and profiling

VOEST ALPINE AG

Metallurgical plant

BAXTER AG

Highly purified factor VIII complex

TURECEK PETER

Method and compositions for specifically detecting physiologically acceptable polymer molecules

Process for the preparation of 11β,21-dihydroxy-2'-methyl-5'βH-1,4-pregnadieno(16,17-D)-oxazole-3,20-dione